ACURA PHARMACEUTICALS, INC. Files 8-K
| Field | Detail |
|---|---|
| Company | Acura Pharmaceuticals, Inc |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
ACURA PHARMACEUTICALS, INC. filed an 8-K on 5/15/25 for 'Other Events' - no major news.
AI Summary
On May 15, 2025, ACURA PHARMACEUTICALS, INC. filed an 8-K report detailing "Other Events." The filing does not contain specific financial figures or significant business developments beyond its routine reporting nature.
Why It Matters
This 8-K filing indicates ACURA PHARMACEUTICALS, INC. has reported an event, but without further details, its immediate market impact is unclear.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any new material information that would significantly impact the company's risk profile.
Key Players & Entities
- ACURA PHARMACEUTICALS, INC. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- 616 N. North Court, Suite 120 (location) — Principal executive offices address
- Palatine, Illinois 60067 (location) — Principal executive offices city, state, zip
- 847-705-7709 (phone_number) — Registrant's telephone number
FAQ
What is the specific nature of the "Other Events" reported by ACURA PHARMACEUTICALS, INC. on May 15, 2025?
The filing states "Other Events" as the item information, but does not provide specific details within the provided text.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 15, 2025.
What is the principal executive office address for ACURA PHARMACEUTICALS, INC.?
The principal executive offices are located at 616 N. North Court, Suite 120, Palatine, Illinois 60067.
What is the telephone number for ACURA PHARMACEUTICALS, INC.?
The registrant's telephone number, including area code, is (847) 705-7709.
What is the Commission File Number for ACURA PHARMACEUTICALS, INC.?
The Commission File Number for ACURA PHARMACEUTICALS, INC. is 1-10113.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding ACURA PHARMACEUTICALS, INC.